Hong Kong · Delayed Price · Currency is HKD Immunotech Biopharm Statistics
Total Valuation
HKG:6978 has a market cap or net worth of HKD 1.72 billion. The enterprise value is 2.03 billion.
| Market Cap | 1.72B |
| Enterprise Value | 2.03B |
Important Dates
The last earnings date was Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6978 has 617.50 million shares outstanding. The number of shares has increased by 6.69% in one year.
| Current Share Class | 617.50M |
| Shares Outstanding | 617.50M |
| Shares Change (YoY) | +6.69% |
| Shares Change (QoQ) | +13.38% |
| Owned by Insiders (%) | 34.64% |
| Owned by Institutions (%) | 0.04% |
| Float | 222.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -89.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.91 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.75% |
| Return on Invested Capital (ROIC) | -27.66% |
| Return on Capital Employed (ROCE) | -156.19% |
| Weighted Average Cost of Capital (WACC) | 6.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.48M |
| Employee Count | 173 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.42% in the last 52 weeks. The beta is 0.57, so HKG:6978's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -23.42% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 3.45 |
| Relative Strength Index (RSI) | 61.74 |
| Average Volume (20 Days) | 312,144 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -194.82M |
| Pretax Income | -256.96M |
| Net Income | -256.82M |
| EBITDA | -128.83M |
| EBIT | -194.82M |
| Earnings Per Share (EPS) | -0.47 |
Balance Sheet
The company has 172.00 million in cash and 489.93 million in debt, with a net cash position of -317.93 million or -0.51 per share.
| Cash & Cash Equivalents | 172.00M |
| Total Debt | 489.93M |
| Net Cash | -317.93M |
| Net Cash Per Share | -0.51 |
| Equity (Book Value) | -19.15M |
| Book Value Per Share | -0.03 |
| Working Capital | -355.28M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 67.14M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:6978 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.69% |
| Shareholder Yield | -6.69% |
| Earnings Yield | -14.96% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |